Federal Register - March 2, 2021

Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.

Source: Federal Register

12196

Federal Register / Vol. 86, No. 39 / Tuesday, March 2, 2021 / Notices
jbell on DSKJLSW7X2PROD with NOTICES

Medicine Board of Scientific Counselors.
The meeting will be open to the public as indicated below. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations should notify the Contact Person listed below in advance of the meeting.
The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552bc6, Title 5 U.S.C., as amended for review, discussion, and evaluation of individual intramural programs and projects conducted by the NATIONAL
LIBRARY OF MEDICINE, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Library of Medicine Board of Scientific Counselors.
Date: April 22, 2021.
Open: April 22, 2021, 11:00 a.m. to 12:30
p.m.
Agenda: Program Discussion and Senior Investigator Report.
Place: Virtual Meeting.
Closed: April 22, 2021, 12:30 p.m. to 12:45
p.m.
Agenda: To review and evaluate personal qualifications, performance, and competence of individual investigators.
Open: April 22, 2021, 12:45 p.m. to 3:45
p.m.
Agenda: Senior Investigator Report.
Closed: April 22, 2021, 3:45 p.m. to 4:15
p.m.
Agenda: To review and evaluate personal qualifications, performance, and competence of individual investigators.
Contact Person: Valerie Florance, Ph.D., Acting Scientific Director, National Library of Medicine, National Institutes of Health, 6705
Rockledge Drive, Suite 500, Bethesda, MD
20892, 3014966221, floranc@mail.nih.gov.
Any member of the public may submit written comments no later than 15 days after the meeting. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Open sessions of this meeting will be broadcast to the public, and available for viewing at https videocast.nih.gov on April 22, 2021. Please direct any questions to the Contact Person listed on this notice.
Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS

VerDate Sep<11>2014

17:11 Mar 01, 2021

Jkt 253001

Dated: February 24, 2021.
Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202104225 Filed 3121; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis Panel Member Conflict: Cognitive and Neuropathological signatures of Alzheimers Disease, Brain Injury and Aging.
Date: March 23, 2021.
Time: 9:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Samuel C. Edwards, Ph.D., Chief, BDCN IRG, Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5210, MSC 7846
Bethesda, MD 20892, 301 4351246, edwardss@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel:
Fogarty Global Brain Disorders.
Date: March 2324, 2021.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 Virtual Meeting.
Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217B, MSC 7846 Bethesda, MD 20892 301435
1259 nadis@csr.nih.gov.
Name of Committee: Center for Scientific Review, Special Emphasis Panel; Member Conflict: Child Psychopathology, Developmental Disabilities, and Mechanisms of Anxiety and Depression.
Date: March 25, 2021.

PO 00000

Frm 00028

Fmt 4703

Sfmt 4703

Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 Virtual Meeting.
Contact Person: Biao Tian, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3089B, MSC 7848 Bethesda, MD
20892, 301 4024411 tianbi@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Antiviral Therapeutics.
Date: March 2930, 2021.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 Virtual Meeting.
Contact Person: Bidyottam Mittra, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive Bethesda, MD
20894 3014354057 bidyottam.mittra@
nih.gov Name of Committee: Center for Scientific Review Special Emphasis Panel; Member conflict: Dermatology Development and Disease.
Date: March 29, 2021.
Time: 12:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 Virtual Meeting.
Contact Person: Richard Ingraham, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4116, MSC 7814 Bethesda, MD 20892, 301 496
8551 ingrahamrh@mail.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333, 93.337, 93.39393.396, 93.83793.844, 93.84693.878, 93.892, 93.893, National Institutes of Health, HHS
Dated: February 24, 2021.
Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202104229 Filed 3121; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10a of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Cancer Institute Clinical Trials and Translational Research Advisory Committee.
The meeting will be held as a virtual meeting and is open to the public.

E:FRFM02MRN1.SGM

02MRN1

Riguardo a questa edizione

Federal Register - March 2, 2021

TitoloFederal Register

PaeseStati Uniti

Data02/03/2021

Conteggio pagine187

Numero di edizioni7798

Prima edizione14/03/1936

Ultima edizione18/06/2026

Scarica questa edizione

Altre edizioni

<<<Marzo 2021>>>
DLMMJVS
123456
78910111213
14151617181920
21222324252627
28293031